Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 446Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Kaletra

PharmaCompass

01

Brand Name : Kaletra

arrow
euroPLX 86 Munich
Not Confirmed

Lopinavir/Ritonavir

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2017 Revenue in Millions : 423

2016 Revenue in Millions : 549

Growth (%) : -23

Abbvie Company Banner

02

Brand Name : Kaletra

arrow
euroPLX 86 Munich
Not Confirmed

Lopinavir/Ritonavir

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2016 Revenue in Millions : 549

2015 Revenue in Millions : 700

Growth (%) : -22

Abbvie Company Banner

03

Brand Name : Kaletra

arrow
euroPLX 86 Munich
Not Confirmed

Lopinavir/Ritonavir

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2015 Revenue in Millions : 870

2014 Revenue in Millions : 700

Growth (%) : -20%

Abbvie Company Banner

04

Brand Name : Kaletra

arrow
euroPLX 86 Munich
Not Confirmed

Lopinavir/Ritonavir

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2018 Revenue in Millions : 336

2017 Revenue in Millions : 423

Growth (%) : -21%

Abbvie Company Banner

05

06

Brand Name : Kaletra

arrow
euroPLX 86 Munich
Not Confirmed

Lopinavir/Ritonavir

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2014 Revenue in Millions : -9.60%

2013 Revenue in Millions :

Growth (%) :

Abbvie Company Banner